Current Urology (Sep 2022)

The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer

  • Luca Di Gianfrancesco,
  • Mauro Ragonese,
  • Giuseppe Palermo,
  • Emilio Sacco,
  • Foschi Nazario,
  • PierFrancesco Bassi,
  • Marco Racioppi

DOI
https://doi.org/10.1097/CU9.0000000000000131
Journal volume & issue
Vol. 16, no. 3
pp. 172 – 174

Abstract

Read online

Abstract. Despite several efforts in the search for noninvasive biomarkers to provide prognostic information for noninvasive muscle bladder cancer, none have shown significant potential. In this context, standard urinalysis is still necessary to provide many data. This method is an inexpensive, simple, and easy-to-repeat tool to follow-up patients over time. Urinalysis does not fall within study protocols and allows evaluation of the immune activation/response (even if indirectly). As such, this method can certainly provide useful information for prognosis.